SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cyclo Therapeutics, Inc. – ‘10-Q’ for 3/31/21 – ‘EXCEL’

On:  Friday, 5/14/21, at 4:02pm ET   ·   For:  3/31/21   ·   Accession #:  1437749-21-12317   ·   File #:  1-39780

Previous ‘10-Q’:  ‘10-Q’ on 11/12/20 for 9/30/20   ·   Next:  ‘10-Q’ on 8/16/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/14/21  Cyclo Therapeutics, Inc.          10-Q        3/31/21   39:2.2M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    222K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     18K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
12: R1          Document And Entity Information                     HTML     45K 
13: R2          Consolidated Balance Sheets (Current Period         HTML     89K 
                Unaudited)                                                       
14: R3          Consolidated Balance Sheets (Current Period         HTML     24K 
                Unaudited) (Parentheticals)                                      
15: R4          Consolidated Statements of Operations (Unaudited)   HTML     69K 
16: R5          Consolidated Statements of Stockholders' Equity     HTML     45K 
                (Unaudited)                                                      
17: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     80K 
18: R7          Note 1 - Summary of Significant Accounting          HTML     53K 
                Policies                                                         
19: R8          Note 2 - Revenues                                   HTML     32K 
20: R9          Note 3 - Major Customers and Suppliers              HTML     18K 
21: R10         Note 4 - Mortgage Note Receivable                   HTML     16K 
22: R11         Note 5 - Note Payable                               HTML     16K 
23: R12         Note 6 - Equity Transactions                        HTML     28K 
24: R13         Note 7 - Income Taxes                               HTML     18K 
25: R14         Note 8 - Equity Incentive Plan                      HTML     16K 
26: R15         Note 9 - Subsequent Events                          HTML     16K 
27: R16         Significant Accounting Policies (Policies)          HTML    100K 
28: R17         Note 2 - Revenues (Tables)                          HTML     26K 
29: R18         Note 1 - Summary of Significant Accounting          HTML     27K 
                Policies (Details Textual)                                       
30: R19         Note 2 - Revenues (Details Textual)                 HTML     20K 
31: R20         Note 2 - Revenues - Revenues by Product (Details)   HTML     25K 
32: R21         Note 3 - Major Customers and Suppliers (Details     HTML     29K 
                Textual)                                                         
33: R22         Note 4 - Mortgage Note Receivable (Details          HTML     20K 
                Textual)                                                         
34: R23         Note 5 - Note Payable (Details Textual)             HTML     14K 
35: R24         Note 6 - Equity Transactions (Details Textual)      HTML    133K 
36: R25         Note 8 - Equity Incentive Plan (Details Textual)    HTML     23K 
38: XML         IDEA XML File -- Filing Summary                      XML     61K 
37: EXCEL       IDEA Workbook of Financial Reports                  XLSX     38K 
 6: EX-101.INS  XBRL Instance -- ctdh-20210331                       XML    507K 
 8: EX-101.CAL  XBRL Calculations -- ctdh-20210331_cal               XML     77K 
 9: EX-101.DEF  XBRL Definitions -- ctdh-20210331_def                XML    601K 
10: EX-101.LAB  XBRL Labels -- ctdh-20210331_lab                     XML    512K 
11: EX-101.PRE  XBRL Presentations -- ctdh-20210331_pre              XML    604K 
 7: EX-101.SCH  XBRL Schema -- ctdh-20210331                         XSD     90K 
39: ZIP         XBRL Zipped Folder -- 0001437749-21-012317-xbrl      Zip     75K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/21  Cyclo Therapeutics, Inc.          424B5                  1:264K                                   RDG Filings/FA
11/16/21  Cyclo Therapeutics, Inc.          424B5                  1:265K                                   RDG Filings/FA
 8/16/21  Cyclo Therapeutics, Inc.          424B5                  1:242K                                   RDG Filings/FA
 5/21/21  Cyclo Therapeutics, Inc.          S-3/A                  2:236K                                   RDG Filings/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/10/20  Cyclo Therapeutics, Inc.          8-K:3,5,9  11/06/20    4:1.2M                                   RDG Filings/FA
Top
Filing Submission 0001437749-21-012317   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 3:40:28.1pm ET